Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
News Commentary on Nicastrin
15 September 2000. Through a nice piece of protein chemistry work, Yu and colleagues from Peter St. George Hyslop’s laboratory have shown that a novel protein, named nicastrin, associates with preseniln 1 and presenilin 2 (Yu G, et al., Nature 407:48, 2000). Surprisingly, this association of nicastrin and presenilins affects APP processing and Aβ generation. That other molecules may be associated with the presenilins has been suspected for some time since the PS complex has been estimated to be from 250,000-over one million kDa.

Nicastrin is a 75 kDa protein that was isolated at stoichiometric levels to PS1. Engineered amino acid substitutions of nicastrin at the DYIGS motif that is conserved between the nicastrin homologs, enhanced release of both Aβ40 and Aβ42. Deletion mutants of DYIGS paradoxically reduced Aβ production, a situation that has been described at certain positions in PS1. In C. elegans, reduced activity of the nicastrin homolog produced notch/glp-1 phenotypes, consistent with the concept that nicastin may facilitate Notch and APP proteolysis. From these intriguing first set of results, much work needs to be done.

Nevertheless, it certainly indicates that a functional complex consisting of presenilins and nicastrin work in coordination to facilitate Notch and APP signaling. It also indicates that simple reconstitution of presenilins and APP (or notch) is unlikely to demonstrate biological activity. For those who believe that presenilins are γ-secretases, this report is not against that notion. For those who feel that presenilins are not the actual γ-secretases, this report suggests that there is much more behind how presenilins work. Indeed, the full complex has yet to be fully eludicated and the actual protease activity remains to be discovered.-by Eddie Koo.

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad